Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Why Are Sponsors Prioritizing Ophthalmology Clinical Trials?
Explore how demographic shifts and retinal innovation are transforming ophthalmology trials, and why operational precision is the key to protecting data integrity in this high-growth sector.
Why Community-Rooted Recruitment Is The Future Of Clinical Trials
Despite clinical trial awareness campaigns and site expansions, trials continue to fall short in reaching the patients who need them most, resulting in a shift toward community-rooted recruitment.
Evaluating Adaptive Trials: Do They Align With Your Study's Goals?
In this short video as Robin Bliss, Vice President, Strategic Consulting at Veristat, shares four key questions that she likes to ask when planning an adaptive design clinical trial.
Medical Insight's Role In Early-Phase Clinical Development
Medical insight reduces risk, strengthens protocols, and accelerates timelines — enhancing safety, feasibility, and collaboration for successful trials and reliable outcomes.

The Implications Of Semaglutide's Connect To Increased Risk Of NAION
2/18/2025

Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).
Advancing Dose Escalation Strategies With Bayesian Modeling
8/12/2025

A CRO was engaged to help a biotechnology sponsor develop a novel oncology therapy design and execute a multicenter, open-label Phase 1/2 dose escalation and expansion study in advanced solid tumors.
Tracking Functional Capacity To Advance Neuromuscular Disease Research
2/6/2026

This presentation introduces a dual-endpoint approach to monitoring neuromuscular disease progression through two high-centile digital measures.
At-Home Clinical Trials: When At-Home Ophthalmic Exams Make Sense
12/23/2025

At-home ophthalmic exams in clinical trials improve patient accessibility, reduce site burden, and maintain data integrity, enabling decentralized research without sacrificing quality or compliance.
Key Strategies For Clinical Development In Rare Cancers
2/11/2025

Successful execution of rare cancer clinical trials requires strategic patient recruitment, innovative trial design, and specialized expertise from Oncology CROs.

Get It Right The First Time: Strategic Clinical Development

Start early and get it right the first time. Course correct with a changing landscape. Overcome obstacles within clinical development. Collaborate with the best strategists and problem-solvers in clinical development.
Endocrine & Metabolic Expertise To Enable Your Success

Veristat has built a team of scientific-minded experts who have supported more than 300 projects for endocrine/metabolic disorder treatments and prepared over 30 marketing applications, 60% of which have been approved or authorized to date.
Integrating Lyft Pass To Increase Flexibility For Trial Participants

Whether used for routine appointments or trial participation, Lyft Pass ensures that patients have timely access to transportation, supporting adherence to schedules and improving overall engagement.
Overcome Biosafety Challenges With An Innovative IBC

Simplify biosafety oversight and accelerate study startup with expert guidance that ensures NIH compliance while protecting researchers, communities, and the environment.
Combining Automation And Human Expertise For Custom Kitting

While automated inventory management systems play a crucial role in tracking samples, kit availability, and supply levels human involvement is still important to the adaptability of a clinical trial.